AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitabet M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

East West Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitabet M 50mg/500mg Tablet

DiaBeta Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like vision impairment and kidney disease, potentially lowering heart attack and stroke risk. DiaBeta Duo 50mg/500mg may be prescribed independently or in conjunction with other diabetic treatments. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood sugar readings, and concurrent medications. Consuming it with meals minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Continued adherence to your prescribed diet and exercise plan is crucial for effective diabetes management; lifestyle choices are key to controlling the disease. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headaches, and sore throat. Hypoglycemia, a potential side effect when used with insulin or sulfonylureas, necessitates awareness of its symptoms and management strategies. This medication isn't suitable for all patients. Prior to use, inform your doctor of any history of liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or breastfeeding individuals should seek medical counsel. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Sitabet M 50mg/500mg Tablet

No text was provided to rewrite.

Uses of Sitabet M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitabet M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Sitabet M 50mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Sitabet M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitabet M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sitabet M 50mg/500mg Tablet with a meal.

How Sitabet M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitabet M 50mg/500mg tablets, offer enhanced blood glucose management. Sitagliptin boosts insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This synergistic action leads to superior blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Sitabet M 50mg/500mg tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitabet M 50mg/500mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to any prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Sitabet M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with impaired kidney function should use Sitabet M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in patients experiencing severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Use of Sitabet M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Sitabet M 50mg/500mg Tablet :

Should you forget a dose of Sitabet M 50mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitabet M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Sitabet M 50mg/500mg Tablet

Sitabet M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitabet M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitabet M 50mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitabet M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitabet M 50mg/500mg Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitabet M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitabet M and seek immediate medical attention.
Sitabet M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitabet M 50mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitabet M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining Sitabet M 50mg/500mg Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin 50mg/500mg tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin immediately and seek medical attention.
Prolonged use of Sitabet M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitabet M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitabet M 50mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitabet M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitabet M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Sitabet M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitabet M and seek immediate medical attention.
Prolonged use of Sitabet M 50mg/500mg Tablet can lead to vitamin B12 deficiency by impairing its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the label's storage instructions. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitabet M 50mg/500mg Tabl...
158
MRP 183
13% off